Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Kühne
Eltrombopag: An Update on the Novel, Non-Peptide Thrombopoietin Receptor Agonist for the Treatment of Immune Thrombocytopenia
Annals of Hematology
Medicine
Hematology
Overexpression of Human Dickkopf-1, an Antagonist of Wingless/WNT Signaling, in Human Hepatoblastomas and Wilms’ Tumors
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Related publications
Eltrombopag, a Thrombopoietin- Receptor Agonist in the Treatment of Adult Chronic Immune Thrombocytopenia: A Review of the Efficacy and Safety Profile
Therapeutic Advances in Hematology
Hematology
The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia
European Oncology and Haematology
Oncology
Hematology
Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia
American Journal of Hematology
Hematology
The Non-Peptide Thrombopoietin Receptor Agonist Eltrombopag Stimulates Megakaryopoiesis in Bone Marrow Cells From Patients With Relapsed Multiple Myeloma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Eltrombopag-Based Combination Treatment for Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
Deciphering Predictive Factors for Choice of Thrombopoietin Receptor Agonist, Treatment Free Responses, and Thrombotic Events in Immune Thrombocytopenia
Scientific Reports
Multidisciplinary
Thrombopoietin Receptor Agonists for the Treatment of Inherited Thrombocytopenia
Haematologica
Hematology
Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia
British Journal of Haematology
Hematology
